Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic Variability

Background: Cardiovascular disease is a frequent complication of type 1 diabetes (T1D). We evaluated the effectiveness of switching from glargine to degludec in reducing the cardiovascular risk factors, the Framingham risk score (FRS) and visceral adiposity index (VAI) in patients with T1D and autoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnotta, Valentina, Di Bella, Giulia, Pillitteri, Giuseppe, Ciresi, Alessandro, Giordano, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070612/
https://www.ncbi.nlm.nih.gov/pubmed/30093885
http://dx.doi.org/10.3389/fendo.2018.00428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070612/
https://www.ncbi.nlm.nih.gov/pubmed/30093885
http://dx.doi.org/10.3389/fendo.2018.00428

Ejemplares similares